Although we found that Ng levels were significantly higher in APOE ε4 carriers compared to APOE ε4 non-carriers among patients with aMCI due to AD, there was no difference in Ng levels between APOE ε4 carriers and non-carriers with AD dementia, as found previously [25, 70]. The gene discussed is NRGN; the disease is Alzheimer disease.